Molecular characterization of circulating tumour cells identifies predictive markers for outcome in primary, triple‐negative breast cancer patients

mRNA profiles of circulating tumour cells (CTCs) were analysed in patients with triple‐negative breast cancer (TNBC) (pts) before (BT) and after therapy (AT) to identify additional treatment options. 2 × 5 mL blood of 51 TNBC pts and 24 non‐TNBC pts (HR+/HER2−; HR−/HER2+) was analysed for CTCs using...

Descripción completa

Detalles Bibliográficos
Autores principales: Bittner, Ann‐Kathrin, Keup, Corinna, Hoffmann, Oliver, Hauch, Siegfried, Kimmig, Rainer, Kasimir‐Bauer, Sabine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7412423/
https://www.ncbi.nlm.nih.gov/pubmed/32558176
http://dx.doi.org/10.1111/jcmm.15349

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7412423/
https://www.ncbi.nlm.nih.gov/pubmed/32558176
http://dx.doi.org/10.1111/jcmm.15349

Ejemplares similares